Morning Buzz: International Business Machines Corporation (NYSE:IBM), Cempra, Inc. (NASDAQ:CEMP), American Capital Mortgage Investment (NASDAQ:MTGE), Johnson & Johnson (NYSE:JNJ), j2 Global (NASDAQ:JCOM)

International Business Machines Corporation (NYSE:IBM) belongs to Technology sector. Its net profit margin is 15.90% and weekly performance is 2.19%. On last trading day company shares ended up $168.61. International Business Machines Corporation (NYSE:IBM) distance from 50-day simple moving average (SMA50) is -0.12%. International Business Machines Corporation (NYSE:IBM) and Corporate America Supports You announced a new initiative Tuesday that connects North Carolina veterans to highly-skilled tech jobs. The program will provide returning service members with hands-on training, certification and job placement. “We’re very excited to be here,” said IBM Vice President Diane Melley. “We’re looking for a high success rate from these veterans and looking forward to welcoming them into corporate America, not only at IBM, but also at our other corporate partnters.”

Cempra, Inc. (NASDAQ:CEMP) shares increased 5.84% in last trading session and ended the day at $38.25. CEMP return on assets is -51.00%. Cempra, Inc. (NASDAQ:CEMP) quarterly performance is 1.51%. On July 10, Cempra Inc. (Nasdaq:CEMP
) said that it has completed enrollment for the global Solitaire-IV Phase 3 trial of solithromycin in adult patients with moderate to moderately severe community-acquired bacterial pneumonia (CABP). Top-line efficacy and safety data from this study are expected to be announced by the end of the year.
On 14 July, American Capital Mortgage Investment Corp. (NASDAQ:MTGE) shares increased 0.18% and was closed at $16.48. MTGE EPS growth in last 5 year was -0.65%. American Capital Mortgage Investment Corp. (NASDAQ:MTGE) year to date (YTD) performance is -7.38%. Wells Fargo & Co. upgraded shares of American Capital Mortgage Investment Corp (NASDAQ:MTGE) from a market perform rating to an outperform rating in a research report sent to investors on Tuesday morning, TheFlyOnTheWall.com reports.

Johnson & Johnson (NYSE:JNJ) shares moved down -0.49% in last trading session and ended the day at $99.78. JNJ Gross Margin is 69.30% and its return on assets is 15.70%. Johnson & Johnson (NYSE:JNJ) quarterly performance is -0.01%. Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky downplayed the threat of biosimilar competition in the US for its top-selling drug Remicade, telling investors he expects the biosimilar market to operate differently than the generic one. Remicade generated $1.6 billion in sales forJohnson & Johnson in the second quarter of 2015, down 7.5% compared to the $1.8 billion it reported in the same quarter in 2014. Hospira, which is being acquired by Pfizer, and Celltrion have filed applications to market copycat versions of Remicade in the US.

j2 Global, Inc. (NASDAQ:JCOM) shares increased 1.81% in last trading session and ended the day at $68.74. JCOM Gross Margin is 82.30% and its return on assets is 8.60%. j2 Global, Inc. (NASDAQ:JCOM) quarterly performance is 0.87%. j2 Global, Inc. (NASDAQ:JCOM) invites the public, members of the press, the financial community, stockholders and other interested parties to listen to a live audio Webcast of its Second Quarter Earnings Call at 4 p.m. Eastern Time on Tuesday August 4th, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *